Organigram Global (OGI) Net Cash Flow Growth (1y) (2019 - 2026)
Organigram Global (OGI) Net Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -1,020.00% |
| 10 | Organigram Global | 122.27 Mn | 155.35 Mn | 28.97 Mn | -101.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.23% |
| Dec 31, 2025 | 68.39% |
| May 31, 2021 | -115.42% |
| Feb 28, 2021 | -177,586.24% |
| Nov 30, 2020 | 1,499,403.66% |
| Aug 31, 2020 | -2,995.38% |
| May 31, 2020 | -90.18% |
| Feb 29, 2020 | 122.67% |
| Nov 25, 2019 | -118.02% |
| Aug 31, 2019 | 122.66% |